Encore Diagnostics, LLC

Encore Diagnostics, LLC was paid $1.63M by Medicaid between Jan 2021 and Sep 2023, across 9 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 66% of everything it billed.

33Billing provider infoENCORE DIAGNOSTICS, LLC
TROY, MI 48084

33aNPI1598351538assigned 12/14/2020

33bProvider typeClinical Medical Laboratory

28Total paid$1.63M

24GClaims36,459

24DCodes billed9

24AFirst – last monthJan 2021 – Sep 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#31 of 108

Median peer was paid$588K

This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	22,493	$946K
2022	11,283	$463K
2023	2,683	$224K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	66%	17,308	16,281	$1.08M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	21%	16,918	15,915	$345K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	12%	1,837	1,731	$200K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	88	60	$3K
87529		<1%	62	60	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	60	58	$610.05
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	62	60	$552.01
87511		<1%	62	60	$493.85
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	62	60	$464.86

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGABALI, ALI (AUTHORIZED OFFICIAL)

Same official

Other billing entities under GABALI, ALI

Full network →

Provider	Location	Paid
Michigan Innovative Diagnostics LLC	Shelby Township, MI	$272K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.